Table 3.

Changes in BA Levels in Patients With CD

StudyWeng et al42Das et al35Jansson et al41Kruis et al37Koga et al39Fiasse et al40Karbach et al44Linnet et al43Wilson et al32Rutgeerts et al45Rutgeerts et al46
SampleFFFFFFSSPDD
Disease location//////Ileal involvement//L2L3L2
<30 cm>30 cm
Total BAs
CA
CDCA
DCA
LCA
UDCA
GCA↑ (PO)↓ (FA and PO)
GCDCA
TCA
TCDCA↓ (FA)
StudyWeng et al42Das et al35Jansson et al41Kruis et al37Koga et al39Fiasse et al40Karbach et al44Linnet et al43Wilson et al32Rutgeerts et al45Rutgeerts et al46
SampleFFFFFFSSPDD
Disease location//////Ileal involvement//L2L3L2
<30 cm>30 cm
Total BAs
CA
CDCA
DCA
LCA
UDCA
GCA↑ (PO)↓ (FA and PO)
GCDCA
TCA
TCDCA↓ (FA)

Only BAs for which at least 2 studies reported alterations are displayed.

↑ = higher level in patients with CD compared with HCs; ↓ = lower level in patients with CD compared with HCs; / = no information available. Empty boxes indicate that no significant difference or no information was provided in the studies.

D indicates fasting duodenal bile; BA, bile acid; CA, cholic acid; CDCA, chenodeoxycholic acid; DCA, deoxycholic acid; F, feces; FA, fasting; GCA, glycocholic acid; GCDCA, glycochenodeoxycholic acid; L2/L3, colitis/ileocolitis; LCA, lithocholic acid; P, plasma; PO, postprandial; S, serum; TCA, taurocholic acid; TCDCA, taurochenodeoxycholic acid; UDCA, ursodeoxycholic acid.

Table 3.

Changes in BA Levels in Patients With CD

StudyWeng et al42Das et al35Jansson et al41Kruis et al37Koga et al39Fiasse et al40Karbach et al44Linnet et al43Wilson et al32Rutgeerts et al45Rutgeerts et al46
SampleFFFFFFSSPDD
Disease location//////Ileal involvement//L2L3L2
<30 cm>30 cm
Total BAs
CA
CDCA
DCA
LCA
UDCA
GCA↑ (PO)↓ (FA and PO)
GCDCA
TCA
TCDCA↓ (FA)
StudyWeng et al42Das et al35Jansson et al41Kruis et al37Koga et al39Fiasse et al40Karbach et al44Linnet et al43Wilson et al32Rutgeerts et al45Rutgeerts et al46
SampleFFFFFFSSPDD
Disease location//////Ileal involvement//L2L3L2
<30 cm>30 cm
Total BAs
CA
CDCA
DCA
LCA
UDCA
GCA↑ (PO)↓ (FA and PO)
GCDCA
TCA
TCDCA↓ (FA)

Only BAs for which at least 2 studies reported alterations are displayed.

↑ = higher level in patients with CD compared with HCs; ↓ = lower level in patients with CD compared with HCs; / = no information available. Empty boxes indicate that no significant difference or no information was provided in the studies.

D indicates fasting duodenal bile; BA, bile acid; CA, cholic acid; CDCA, chenodeoxycholic acid; DCA, deoxycholic acid; F, feces; FA, fasting; GCA, glycocholic acid; GCDCA, glycochenodeoxycholic acid; L2/L3, colitis/ileocolitis; LCA, lithocholic acid; P, plasma; PO, postprandial; S, serum; TCA, taurocholic acid; TCDCA, taurochenodeoxycholic acid; UDCA, ursodeoxycholic acid.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close